Company Overview of Van Eck Associates Corporation
Van Eck Associates Corporation is an employee owned investment manager. The firm provides its services to investment companies. It also caters to pooled investment vehicles, pension and profit sharing plans, charitable organizations, and state or municipal government entities. It manages separate client focused equity and fixed income portfolios for its clients. The firm also launches and manages equity, fixed income, commodity, and balanced mutual funds for its clients. It invests in the public equity and fixed income markets across the globe. The firm also invests in alternatives investments markets including hard assets, real estate, precious metals, and natural resources like gold to con...
666 Third Avenue
New York, NY 10017
Founded in 1955
Key Executives for Van Eck Associates Corporation
Chief Executive Officer, President, Principal, Member of Executive Management Team, Chairman, and Director
Chief Financial Officer, Senior Vice President, Controller, Treasurer, Director, and Member of Corporate Management Committee
Chief Administrative Officer and Vice President
General Counsel, Secretary, and Vice President
Compensation as of Fiscal Year 2016.
Van Eck Associates Corporation Key Developments
Van Eck Associates Corporation Presents at FX Invest North America, Apr-12-2016 04:30 PM
Apr 6 16
Van Eck Associates Corporation Presents at FX Invest North America, Apr-12-2016 04:30 PM. Venue: The Langham Boston Hotel, 250 Franklin Street, Boston, MA 02110, United States. Speakers: Natalia Gurushina, Economist.
Van Eck Global Launches Market Vectors Generic Drugs ETF
Jan 13 16
Van Eck Global has launched the Market Vectors Generic Drugs ETF (GNRX), the first and only Exchange-Traded Fund (ETF) to target global manufacturers of generic drugs and biosimilars, similar copies of existing but difficult to replicate biological drugs. GNRX seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Indxx Global Generics & New Pharma Index. To be included in the Index, companies must derive a significant proportion of their revenues (or have the potential to derive a significant proportion of their revenues) from the generic drug industry or have a primary business focus on the generic drug industry. Constituents must also meet market capitalization, daily trading volume, and daily trading activity requirements. Van Eck notes that an investment in GNRX incurs risks which include those associated with investments in the pharmaceutical and biotechnology sectors as well as foreign and emerging markets investments, particularly those concentrated in India and Ireland. GNRX has a gross expense ratio of 0.63% and net expense ratio of 0.55%, which is capped contractually until February 1, 2017. GNRX joins Van Eck Global's family of healthcare-focused industry ETFs, which also includes Market Vectors Biotech ETF and Market Vectors Pharmaceutical ETF.
Van Eck Global Presents at Public Funds Summit 2016, Jan-14-2016 09:20 AM
Dec 31 15
Van Eck Global Presents at Public Funds Summit 2016, Jan-14-2016 09:20 AM. Venue: Fairmont Scottsdale Princess, Scottsdale, Arizona, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions